Selected article for: "coronavirus virus and effective strategy"
Author: Ahmad, Ajaz; Raish, Mohammad; Alkharfy, Khalid M.
Title: The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19
  • Cord-id: n0cxouq0
  • Document date: 2021_7_23
    • ID: n0cxouq0
    Snippet: A new virus strain detected in late 2019 and not previously described in humans is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes corona virus disease (COVID-19). While potential therapeutic approaches for COVID-19 are being investigated, significant initiatives are being made to create protective drugs and study various antiviral agents to cure the infection. However, an effective treatment strategy against COVID-19 is worrisome inadequate. The objective of the p
    Document: A new virus strain detected in late 2019 and not previously described in humans is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes corona virus disease (COVID-19). While potential therapeutic approaches for COVID-19 are being investigated, significant initiatives are being made to create protective drugs and study various antiviral agents to cure the infection. However, an effective treatment strategy against COVID-19 is worrisome inadequate. The objective of the present manuscript is to discuss the potential role of thymoquinone (TQ) in preventing the cardiovascular complications of COVID-19, focusing on viral inhibition, antioxidant potential, vascular effect, and cardiac protection. The multifunctional properties of TQ could potentially synergize with the activity of current therapeutic interventions and offer a basis for managing COVID-19 disease more effectively. Even though the experimental evidence is positive, a translational application of TQ in COVID-19 is timely warranted.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor receptor blocker and acute coronary syndrome: 1
    • ace inhibitor receptor blocker and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • aceis angiotensin converting enzyme inhibitor and acute respiratory syndrome: 1, 2
    • active constituent and acute respiratory syndrome: 1, 2
    • acute respiratory syndrome and adenine dinucleotide: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and adenine dinucleotide phosphate: 1, 2, 3, 4, 5